Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection (Q35941512)

11 August 2017

Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection (English)

1 reference

11 August 2017

0 references

10

Michal Chowers

1 reference

11 August 2017

13

Bibiana Chazan

1 reference

11 August 2017

7

Yonit Wiener-Well

1 reference

11 August 2017

Dimitrios P Kontoyiannis

18

object named as

Dimitrios P Kontoyiannis

1 reference

11 August 2017

Ronen Ben-Ami

1

1 reference

11 August 2017

Keren Olshtain-Pops

2

1 reference

11 August 2017

Michal Krieger

3

1 reference

11 August 2017

Ilana Oren

4

1 reference

11 August 2017

Jihad Bishara

5

1 reference

11 August 2017

Michael Dan

6

1 reference

11 August 2017

Miriam Weinberger

8

1 reference

11 August 2017

Oren Zimhony

9

1 reference

11 August 2017

Gabriel Weber

11

1 reference

11 August 2017

Israel Potasman

12

1 reference

11 August 2017

Imad Kassis

14

1 reference

11 August 2017

Itamar Shalit

15

1 reference

11 August 2017

Colin Block

16

1 reference

11 August 2017

Nathan Keller

17

1 reference

11 August 2017

Michael Giladi

19

1 reference

11 August 2017

Israeli Candidemia Study Group

20

1 reference

11 August 2017

language of work or name

English

0 references

publication date

6 February 2012

1 reference

11 August 2017

6

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

11 August 2017

56

1 reference

11 August 2017

5

1 reference

11 August 2017

2518-2523

1 reference

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Risk factors for fluconazole-resistant candidemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Risk factors for fluconazole-resistant Candida glabrata bloodstream infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Antifungal activity of nonantifungal drugs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Estimating causal effects from large data sets using propensity scores

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Inhibition by sulfonamides of the candidacidal activity of human neutrophils

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346668

Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study

24 September 2018

1 reference

12 December 2020

Interactions between amphotericin B and nitroimidazoles against Candida albicans

1 reference

12 December 2020

Influence of fluoroquinolones on phagocytosis and killing of Candida albicans by human polymorphonuclear neutrophils

1 reference

12 December 2020

Amphotericin B-metronidazole combination against Candida spp

1 reference

12 December 2020

Combined activity of ketoconazole and sulphamethoxazole against Candida albicans

1 reference

12 December 2020

“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy

1 reference

12 December 2020

Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.05947-11

1 reference

11 August 2017

1 reference

11 August 2017

1 reference